S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.41 (+0.72%)
BABA   85.91 (-1.50%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.43 (-1.19%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.20%)
GE   109.93 (-1.60%)
DIS   80.05 (-1.19%)
AMC   7.91 (-2.83%)
PFE   32.40 (-1.76%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.41 (+0.72%)
BABA   85.91 (-1.50%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.43 (-1.19%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.20%)
GE   109.93 (-1.60%)
DIS   80.05 (-1.19%)
AMC   7.91 (-2.83%)
PFE   32.40 (-1.76%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.41 (+0.72%)
BABA   85.91 (-1.50%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.43 (-1.19%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.20%)
GE   109.93 (-1.60%)
DIS   80.05 (-1.19%)
AMC   7.91 (-2.83%)
PFE   32.40 (-1.76%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.41 (+0.72%)
BABA   85.91 (-1.50%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.43 (-1.19%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.20%)
GE   109.93 (-1.60%)
DIS   80.05 (-1.19%)
AMC   7.91 (-2.83%)
PFE   32.40 (-1.76%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
NASDAQ:OPGN

OpGen (OPGN) Earnings Date, Estimates & Call Transcripts

$0.22
-0.01 (-4.44%)
(As of 09/26/2023 ET)
Compare
Today's Range
$0.21
▼
$0.23
50-Day Range
$0.17
▼
$0.65
52-Week Range
$0.17
▼
$9.05
Volume
127,757 shs
Average Volume
373,846 shs
Market Capitalization
$1.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 9Estimated
Actual EPS
(Aug. 10)
-$0.93 Missed By -$0.22
Consensus EPS
(Aug. 10)
-$0.71
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

OPGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

OPGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

OpGen Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q2 20231($0.71)($0.71)($0.71) 
Q3 20231($0.43)($0.43)($0.43) 
Q4 20231($0.25)($0.25)($0.25) 
20233($1.39)($1.39)($1.39) 
Q1 20241($0.19)($0.19)($0.19) 
Q2 20241($0.17)($0.17)($0.17) 
Q3 20241($0.16)($0.16)($0.16) 
Q4 20241($0.14)($0.14)($0.14) 
FY 20244($0.66)($0.66) ($0.66)

OPGN Earnings Date and Information

OpGen last posted its quarterly earnings data on August 10th, 2023. The medical research company reported ($0.93) earnings per share for the quarter, missing analysts' consensus estimates of ($0.71) by $0.22. The business earned $0.74 million during the quarter, compared to analysts' expectations of $0.90 million. OpGen has generated ($12.05) earnings per share over the last year (($12.05) diluted earnings per share). Earnings for OpGen are expected to grow in the coming year, from ($2.01) to ($0.65) per share. OpGen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off prior year's report dates.

OpGen Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/9/2023
Estimated)		------- 
8/10/2023Q2 2023($0.71)($0.93)($0.22)($0.93)$0.90 million$0.74 million    
5/15/2023Q1 2023-($1.25)($1.25)($1.25)-$0.91 million
3/29/2023Q4 2022-($1.90)($1.90)$0.07-$0.72 million
11/10/2022Q3 2022-($3.00)($3.00)--$0.45 million
8/11/2022Q2 2022($0.15)($0.13)+$0.02($0.13)$1.00 million$0.97 million
5/12/2022Q1 2022($0.16)($0.15)+$0.01($0.15)$1.05 million$0.47 million
3/29/2022Q4 2021($0.16)($0.35)($0.19)($0.35)$1.40 million$1.43 million    
11/11/2021Q3 2021($0.19)($0.16)+$0.03($0.16)$1.20 million$1.24 million    
8/12/2021Q2 2021($0.20)($0.19)+$0.01($0.19)$1.05 million$0.81 million    
5/13/2021Q1 2021($0.22)($0.29)($0.07)($0.08)$1.66 million$0.83 million
3/24/2021Q4 2020($0.31)($0.37)($0.06)($0.36)$1.30 million$1.35 million  
11/11/2020Q3 2020($0.36)($0.40)($0.04)($0.40)$1.00 million$1.06 million  












OpGen Earnings - Frequently Asked Questions

When is OpGen's earnings date?

OpGen has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off last year's report dates. Learn more on OPGN's earnings history.

Did OpGen beat their earnings estimates last quarter?

In the previous quarter, OpGen (NASDAQ:OPGN) missed the analysts' consensus estimate of ($0.71) by $0.22 with a reported earnings per share (EPS) of ($0.93). Learn more on analysts' earnings estimate vs. OPGN's actual earnings.

How can I listen to OpGen's earnings conference call?

The conference call for OpGen's latest earnings report can be listened to online. Listen to Conference Call

How can I read OpGen's conference call transcript?

The conference call transcript for OpGen's latest earnings report can be read online. Read Transcript

How much revenue does OpGen generate each year?

OpGen (NASDAQ:OPGN) has a recorded annual revenue of $2.61 million.

How much profit does OpGen generate each year?

OpGen (NASDAQ:OPGN) has a recorded net income of -$37.28 million. OPGN has generated -$12.05 earnings per share over the last four quarters.

What is OpGen's EPS forecast for next year?

OpGen's earnings are expected to grow from ($2.01) per share to ($0.65) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:OPGN) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -